MedLumics, a Madrid, Spain-based medical imaging diagnostics company specializing in advanced optical coherence tomography (OCT) technology, closed a €3.5m Series A equity funding.
The round was co-led by Ysios Capital Partners and Caixa Capital Risc.
The company intends to use the funding to complete the development of its imaging diagnostic platform and the recruitment of its executive and technical teams (http://www.medlumics.com/en/Careers).
Founded in 2009 by CEO Eduardo Margallo Balbás, MedLumics is a medical imaging diagnostics company specializing in advanced optical coherence tomography (OCT) technology. Its proprietary platform integrates optical and electrical components in a compact microchip-based OCT system, which can produce dynamic, real-time, high-resolution diagnostic images that allow physicians to perform a non-invasive optical “digital biopsy” of tissues. Initial applications will be focused in dental implantology and intravascular imaging in cardiology as well as other medical specialties that have diagnostic needs not yet addressed by first generation OCT systems.